A Randomized Controlled Trial To Assess the Optimal Dose and Effect of Nebulized Albuterol in Acute Exacerbations of COPD.
- Resource Type
- Article
- Authors
- Nair, Suresh; Thomas, Enson; Pearson, Stanley B.; Henry, Michael T.
- Source
- CHEST. Jul2005, Vol. 128 Issue 1, p48-54. 8p. 4 Diagrams, 2 Charts.
- Subject
- *ALBUTEROL
*OBSTRUCTIVE lung diseases
*CLINICAL trials
*ADRENERGIC beta agonists
*BRONCHODILATOR agents
*RESPIRATORY obstructions
- Language
- ISSN
- 0012-3692
The article compares the bronchodilator's response to incremental doses of inhaled albuterol during and after recovery of acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The result shows significant improvement in maximal bronchodilation to inhaled albuterol as the COPD exacerbation resolved. However, there was no significant difference in outcomes between patient treated with regular 2.5 and 5 milligrams of nebulized albuterol during an AECOPD.